Edge Perspectives

During the COVID-19 surge, many patients deferred seeking care either because services were no longer available, or out of fear of contracting the coronavirus themselves. In this week’s episode, our cardiovascular, medicine and surgery, and orthopedics service line experts explore the various near- and long-term impacts that have resulted from these deferrals. They also discuss site of care shifts, including the shifts to virtual health, which are expected to continue.

Service Line Teams

Cardiovascular - Chad Giese and Josh Aaker

Medicine and Surgery - Justin Cassidy and Catherine Vanacore

Orthopedics - Ryota Terada

Sg2 members can read more here about service line pivots and lasting impact

COVID-19 has forced a rapid shift to virtual health.  Now, health systems—and their virtual health teams—are thinking about the role they should play in antibody testing and digital public health monitoring as well. In this week’s episode, Sg2’s Chris Pagano and Tony Guth not only discuss what has already happened in virtual health and what we anticipate for the future, but also what other countries have done in terms of testing and monitoring and what lessons we can learn as we determine the best role to play.

Sg2 members can read more about virtual health in this recent article and the Virtual Health Newsletter

The health care industry has lagged behind others in viewing patients as consumers even prior to the pandemic and, as systems resume elective services, stakes are higher than ever.  In this week’s episode, Sg2’s Mark Larson and Vizient’s Dr. Tom Villanueva discuss health system approaches to meeting patient needs for safety,  cost and convenience in the wake of COVID-19.

Resources: 

Tom hosted Mark on his podcast, Modern Practice Podcast, where they examined the role of the patient voice in the reopening of elective procedures. The episode, The Role of Patient and Family Councils (PFACs) in Resuming Elective Procedures, is linked here.

For Sg2 Members: Please see related materials, linked below.

Sg2 Expert Insight: Engaging the (Post-COVID-19) Health Care Consumer

Sg2 Report: Consumerism: Service Lines Brace for Impact

Sg2 Webinar: Consumerism 3.0: The Era of Service Line Disruption

In the second episode on how the current physician landscape is being reshaped by COVID-19, Sg2’s Dr David DiLoreto and Mike Strilesky explore COVID-19’s impact on physician practice ownership and physician alignment, as well as how business models are evolving during this unprecedented time.

COVID-19 has introduced significant financial challenges to physician practices and the way they operate. In this first of 2 episodes on how the pandemic is reshaping the physician landscape, Sg2’s Dr David DiLoreto and Mike Strilesky discuss those challenges, along with the opportunities health systems have to innovate their care delivery.

Health systems are in a delicate balancing act, treating COVID-19 patients while still providing essential services. In this episode, Sg2’s cancer, neuroscience and women’s health experts discuss how systems can maintain this balance, how new treatment sites and services are disrupting established care patterns, and the overarching impact on patients in the near- and long-term.

Service line teams:

Cancer – Cory Jones and Kiran Yemul

Neurosciences – Kate Zentner and Gurmeet Bawa

Women’s Health – Karyl Kopaskie and Rhae Gamber

Other Sg2 Resources:

Service Lines Pivot for the Crisis, Now Contend with Lasting Impact

Sg2’s Brian Esser and Ryota Terada share a data-driven approach for health systems reactivating elective procedures on the journey to financial recovery from COVID-19.

For Sg2 Members, please see referenced and related resources below:

COVID-19 Action Steps: Stemming Financial Fallout

COVID-19 Financial Recovery Calculator and Resources

Bill Woodson and Jennifer O'Connor share what they have been hearing from strategy leaders around the country and make recommendations on the many considerations health systems must make as they plan for reactivating/ restarting their traditional business.  The fight against COVID is not over but strategy and planning teams must focus on what comes next.

To make sure you always get the newest episodes of Sg2 Perspectives, please follow us on your favorite podcast platform.

Sg2 Members can read more here https://intel.sg2.com/resource-types/expert-insights/2020/4/COVID-19-Action-Steps_Elective-Surgery/

Henry Soch and Chris Pagano share a few key areas they predicted could be disruptive technology to watch earlier in the year, and explore how their adoption is being accelerated in the fight against Covid. 

More about the Sg2 perspective on Covid https://www.sg2.com/health-care-intelligence-blog/2020/03/in-crisis-dont-underestimate-value-of-strategy/

Sg2 Members can view the Disruptors to Watch webinar from January https://intel.sg2.com/resource-types/events/2020/1/Disrupters-to-Watch-in-2020/

Contact us any time at [email protected] 

Former Sg2 CEO, Steve Lefar, and Bill Woodson discuss the near-term and longer-term financial impact Covid 19 is having on hospitals and health systems.  They talk about the challenging work strategy, finance, and operations leaders are undertaking now to plan and prepare for what comes next, as well as, considerations for payer and provider relations.  

For Sg2 Members: Sg2 Surge Demand Calculator https://intel.sg2.com/resource-types/resource-kits/2020/3/COVID-19_Calculator/

For Vizient Members: https://www.vizientinc.com/covid-19

Sg2 Surge Demand Calculator https://www.sg2.com/sg2-covid-19-surge-demand-calculator/

A Vizient podcast all about the Surge Demand Calculator https://modernpracticepodcast.podbean.com/e/modern-practice-modeling-surge-demand-for-covid-19/

DISCLAIMER: VIZIENT IS COMPILING INFORMATION AND EMERGING PRACTICES FROM MEMBERS TO AID IN KNOWLEDGE TRANSFER DURING THE COVID-19 RESPONSE. DECISIONS REGARDING WHETHER AND HOW TO UTILIZE ANY OF THESE PRACTICES SHOULD BE MADE BY HEALTH CARE PROVIDERS, AT THEIR OWN RISK, WITH CONSIDERATION OF INDIVIDUAL CIRCUMSTANCES. AS INFORMATION IS CHANGING RAPIDLY, VIZIENT ENCOURAGES YOU TO ALWAYS REFER TO THE CDC, YOUR STATE’S DEPARTMENT OF HEALTH, AND YOUR LOCAL PUBLIC HEALTH AUTHORITY FOR GUIDANCE. VIZIENT DOES NOT PROVIDE LEGAL, REGULATORY, OR MEDICAL ADVICE AND DISCLAIMS LIABILITY OR RESPONSBILITY FOR THE ACCURACY, COMPLETENESS, AND/OR CLINICAL EFFICACY NAD SAFETY FOR THE PRODUCTS OR PROCESSES CONTAINED HEREIN. MEMBERS SHOULD SEEK THEIR LEGAL COUNSEL’S ADVICE ON LOCAL, STATE, AND FEDERAL LEGAL/REGULATORY MATTERS. THE LINKS TO INFORMATION REFERENCED IN THIS DOCUMENT ARE THE PRODUCTS OF THE